Mark Awadalla

Title: Vice President of Clinical Operations

Organization: Capricor

2024 FUTURES – Therapies to Preserve and Protect Muscle

Presentations covering therapies aiming to preserve and protect muscle in Duchenne, including anti-inflammatory agents, muscle stabilizers, and other mechanisms with relevant updates from companies in the space.

 

Karyn Koladicz, MD

Executive Medical Director for Medical Affairs, Neurology PTC Therapeutics

See more from same speaker

Lianna Orlando, PhD

Senior Director of Research

CureDuchenne

See more from same speaker

Abby Bronson

Vice President, Patient Advocacy & External Innovation

Edgewise Therapeutics

See more from same speaker

Stanley Iyadurai, MD, PhD

Sr VP Medical Affairs and Drug Discovery

Catalyst

See more from same speaker

Scott Baver, PhD

Head of Medical Affairs

ITF Therapeutics

See more from same speaker

Mark Awadalla

Vice President of Clinical Operations

Capricor

See more from same speaker

Video
Share this:
Beginning the Journey - diagnosed 0-3 yearsGrowth and Transformation - diagnosed 3-6 yearsSpreading Wisdom - diagnosed 6+ years